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Abstract: Our purpose was to study the relationship of adherence to the Mediterranean diet (MedDiet)
with urinary factors that favor the formation of renal calcium and uric acid stones in overweight and
obese participants who had metabolic syndrome. This cross-sectional study examined 267 participants.
A well-known MedDiet score (range 0–9) was calculated for each patient, and patients were then
categorized has having low (≤3), medium (4–5), or high (≥6) adherence to the MedDiet. Baseline
characteristics and urinary parameters were also analyzed. High calcium salt urinary crystallization
risk (CaUCR) and high uric acid urinary crystallization risk (UrUCR) were calculated from urinary
parameters using pre-defined criteria. More than half of patients with MedDiet scores ≤3 had high
UrUCR (55.4%) and high CaUCR (53.8%). In contrast, fewer patients with high adherence (≥6) to the
MedDiet had high UrUCR (41.2%) and high CaUCR (29.4%). Relative to those with low adherence,
individuals with high adherence had a prevalence ratio (PR) of 0.77 for a high UrUCR (95% CI:
0.46–1.12; p for trend: 0.069) and a PR of 0.51 for a high CaUCR (95% CI: 0.26–0.87; p for trend: 0.012)
after adjusting for age, sex, body mass index, type 2 diabetes, and total energy intake. Our findings
indicate that greater adherence to the MedDiet was associated with a reduced CaUCR and a reduced
UrUCR. This suggests that adequate dietary management using the MedDiet patterns may prevent
or reduce the incidence and recurrence of calcium salt and uric acid renal stones.
Keywords: Mediterranean diet; renal lithiasis; urinary crystallization risk
1. Introduction
Renal lithiasis has a multifactorial etiology. Urine composition is a key factor affecting urine
crystal formation, because urine is a metastable liquid containing multiple solutes that can potentially
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crystallize. A disruption in the balance between urinary promoters and inhibitors of crystallization
within the urinary tract, and certain renal macro- and micro-anatomical features can affect crystallization.
The structure and composition of renal calculi vary greatly. They may consist of pure uric acid,
pure hydroxyapatite, calcium oxalate with different compositions, and various mixtures of these
different compounds. Approximately 70–80% of renal calculi are composed of calcium oxalate or
calcium phosphate, about 10–15% are uric acid, 5–10% are struvite, and <1% consist of cysteine or
other compounds, such as drug-related crystals [1,2].
The prevalence of renal lithiasis is increasing globally [2,3]. Although the prevalence is 5–10%
in Europe, some regions have prevalences up to 15%. The recurrence rates are also variable among
different regions, but the overall 10-year recurrence rate is about 50% [1]. The high incidence and
recurrence rate of renal lithiasis make this condition a significant economic cost for most societies.
Many studies have suggested that obesity is a significant contributor to renal lithiasis. In particular,
there is evidence of a 75% increased incidence of renal lithiasis in overweight and obese patients
compared to normal weight counterparts [4]. Metabolic syndrome is also associated with an increased
risk of renal lithiasis, as well as systemic diseases such cardiovascular disease and diabetes mellitus.
It has also been reported that subjects with metabolic syndrome have an increased incidence of uric
acid lithiasis relative to those without metabolic syndrome [5].
Although the etiology of renal lithiasis is multifactorial, diet seems to be an important factor due
to its ability to affect urine composition. Some dietary components, beyond liquid intake, can modify
important factors that increase the risk of renal lithiasis [6–8]. In particular, diet can affect urinary
concentrations of calcium and oxalate, alter urinary pH, and modify the urinary levels of other
factors that prevent crystal formation and growth (urinary crystallization inhibitors), such as citrate
and phytate [7]. Some of these urinary parameters can be considered as risk factors for lithogenic
urine, although they differ in the ability to differentially increase the risk of calcium lithiasis and uric
acid lithiasis.
The aim of the present cross-sectional study was to assess the association between an overall
dietary pattern, specifically the Mediterranean Diet (MedDiet), with urinary parameters known to
favor or prevent renal lithiasis in a subset of participants from the PREDIMED-Plus trial who are
overweight or obese and have the metabolic syndrome.
2. Materials and Methods
2.1. Study Overview and Sample
This study was a cross-sectional analysis of baseline data within the framework of the ongoing
PREDIMED-Plus trial, a six-year parallel-group, multicenter, randomized clinical trial of 6874
participants from 23 recruiting centers in Spain. This trial was designed to evaluate the effect
of several lifestyle interventions—encouragement of weight loss by adoption of an energy-restricted
traditional MedDiet, promotion of physical activity, and provision of behavioral support—on the
primary prevention of cardiovascular morbidity and mortality. The PREDIMED-Plus recruitment
period was from 5 September 2013 to 31 October 2016. The protocol and a detailed description are
reported elsewhere [9] and more information is also available on its website (www.predimedplus.com).
Eligible participants were men and women (aged 55–75 years) who were overweight or obese
(BMI ≥ 27 and < 40 kg/m2), who met at least three criteria for the metabolic syndrome (abdominal
obesity, high blood pressure, high fasting glucose, high triglycerides, and low HDL-cholesterol) [10].
All participants provided written informed consent. The study was approved by the institutional
review boards of all recruiting centers and was performed according to the ethical standards of the
Declaration of Helsinki. The trial was registered at the International Standard Randomized Controlled
Trial (ISRCT: http://www.isrctn.com/ISRCTN89898870) on 24 July 2014. The sub-group of participants
in the present study (n = 267) were consecutively recruited from 27 May 2014 to 29 June 2016 at
University Hospital Son Espases.
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2.2. Dietary Assessment and Mediterranean Diet Score
Data on dietary intake were collected at baseline. All participants were asked to complete a
previously validated 137-item semi-quantitative Spanish-language survey [11,12]. Energy and nutrient
intakes were calculated using a computer program based on available information from Spanish food
composition tables [13,14].
The Mediterranean diet score (MDS), proposed by Trichopoulou et al. [15], was used to evaluate
the consumption of nine foods and nutrients in characteristic of the MedDiet, which were categorized
based on the PREDIMED-Plus-wide sex-specific medians. Individuals with consumption of fruits and
nuts, vegetables, legumes, cereals, fish, and the ratio of monounsaturated fatty acids to saturated fatty
acids (MUFA/SFA) above the median level were each assigned a value of 1 (or 0 if below the median);
consumption of meat and dairy products below the median level was each assigned a value of 1 (or 0 if
above the median); consumption of ethanol of 10–50 g/day for men and 5–25 g/day for women was
assigned a value of 1 (or 0 if outside this range). Thus, the total MDS ranged from 0 to 9, and a higher
score indicated greater adherence to the MedDiet. In this study, the participants were categorized as
having low (≤3), medium (4–5), or high (≥6) adherence to the MedDiet.
2.3. Urine Collection and Analysis
A two-hour spot morning urine sample was collected in the fasting conditions from all participants.
Urinary pH (measured using a Crison pH-meter), and the urinary concentrations of calcium (Ca),
phosphorus (P), oxalate (Ox), uric acid (Ur), citrate (Cit), and magnesium (Mg) were determined. Ca,
P and Mg were measured using inductively coupled plasma tandem atomic emission spectrometry
(ICP-AES), Ur was determined using the uricase method, Ox was determined using the oxalate
oxidase/peroxidase method (LTA, Milano, Italy), and Cit was determined using an enzymatic
assay (Biosystems, Barcelona, Spain). Lithogenic urine was defined by a high calcium salt urinary
crystallization risk (CaUCR) or a high uric acid urinary crystallization risk (UrUCR), in accordance
with the criteria indicated in Table 1 [16–19].
Table 1. Criteria used to define high calcium salt urinary crystallization risk (CaUCR) and high uric
acid urinary crystallization risk (UrUCR), based on [16–19].













UrUCR: at least one of two conditions must be present
pH <5.5
Uric acid >100 mg/dL
2.4. Covariates Assessment
Information on sex and age was collected at enrolment. Baseline body weight (kg) and height (cm),
measured when the subjects were wearing light clothing and no shoes, was determined in duplicate
using a calibrated scale and a wall-mounted stadiometer. Body mass index (BMI) was calculated as
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weight (kg) divided by square of the height (m). Diabetes was defined as self-reported diagnosis at
study inclusion, a baseline HbA1c of 6.5% or more, or use of an antidiabetic medication at baseline,
such as insulin, metformin, and other medications.
2.5. Statistical Analysis
Continuous variables are expressed as means and standard deviations (SDs), and categorical
variables as numbers and percentages. After assessing the normality of data distributions, a one-way
ANOVA (continuous variables) or the Chi-squared test (categorical variables) was used to identify
statistical differences in baseline characteristics and urinary parameters of the three groups.
Univariable and multivariable binary logistic regression were used to determine the association of
dietary factors with CaUCR and UrUCR. Because of the elevated prevalence of high CaUCR and high
UrUCR in our population, odds ratios (ORs) were calculated and then a correction method [20] was
applied to determine prevalence ratios (PRs) to reduce exaggerations of the true relative risk (RR). MDS
was treated as a categorical variable (low, medium or high) using the low category as the reference.
Models were adjusted potential confounders such as age, sex, presence of type 2 diabetes, total daily
energy intake, and BMI. The association of each component of the MDS with CaUCR and with UrUCR
was also determined using similar models. All statistical analyses were performed using SPSS version
23 software, and a two-sided p-value below 0.05 was considered statistically significant.
3. Results
3.1. Baseline Characteristics and Urinary Parameters
The study population (n = 267) had a mean (± SD) age of 65 (± 5) years, a mean BMI of 33 (± 3)
kg/m2, and consisted of 49.4% women. A total of 27.3% of the population had diabetes, 47.5% had high
CaUCR, and 48.3% had high UrUCR. Table 2 shows baseline characteristics and urinary parameters of
the groups with low, medium, and high adherence to the MedDiet. Individuals with low adherence
were younger and had a higher concentration of urinary uric acid, but the other measured parameters
were similar among the three groups.
Table 2. Baseline characteristics and urinary parameters of groups that had low, medium, and high
adherence to the MedDiet. Results are expressed as means ± SDs or n (%).






(n = 34) p-value
b
Age (years) 64 ± 5 66 ± 5 65 ± 5 0.023
Sex (% female) 67 (51.5) 48 (46.6) 17 (50) 0.750
DM (%) 37 (28.5) 26 (25.2) 10 (29.4) 0.830
HTA (%) 116 (89.2) 91 (88.3) 29 (85.3) 0.816
BMI (kg/m2) 33 ± 3 32 ± 3 32 ± 4 0.093
Energy (kcal/day) 2202 ± 665 2275 ± 609 2287 ±4 36 0.603
pH 5.7 ± 0.7 5.8 ± 0.7 5.8 ± 0.7 0.395
Ur (mg/dL) 55 ± 25 47 ± 23 49 ± 26 0.025
P (mg/dL) 74 ± 40 70 ± 37 59 ± 22 0.131
Cit (mg/L) 639 ± 392 568 ± 347 599 ± 367 0.354
Ox (mg/L) 21 ± 9 21 ± 12 21 ± 9 0.976
Ca (mg/dL) 12 ± 9 11 ± 10 9 ± 5 0.297
Mg (mg/dL) 7 ± 5 7 ± 5 7 ± 3 0.446




0.19 (0.07–0.22) * 0.148
DM, diabetes mellitus; HTA, hypertension; BMI, body mass index; Ur, Uric acid; P, phosphorous; Cit, citrate; Ox,
oxalate; Ca, calcium; Mg, magnesium; Ca/Cit ratio, calcium to citrate ratio; a Mediterranean diet adherence was based
on the Mediterranean Diet Score (MDS) [15]. Low: MDS ≤ 3; Medium: MDS = 4 or 5; High: MDS ≥ 6. b One-way
ANOVA for continuous variables; Chi-squared test for categorical variables. * Median (interquartile range).
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3.2. Calcium and Uric Acid Urinary Crystallization Risk
Figure 1 shows the percentages of patients with a high CaUCR and a high UrUCR in the three
groups. There were clear trends of smaller percentages of patients with each condition as MedDiet
adherence increased. Comparison of patients in these different diet adherence categories indicated a
significant difference in high CaUCR (53.8%, 45.6%, 29.4%; p = 0.012) and a nearly significant difference
in high UrUCR (55.4%, 41.7%, 41.2%; p = 0.079).
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Figure 1. Percentage of subjects with high calcium urinary crystallization risk (CaUCR) and high uric
acid urinary crystallization risk (UrUCR) who had low, medium, and high adherence to the MedDiet.
Chi-squared tests indicated that high CaUCR had a significant association with diet (p = 0.012) and
high UrUCR had a marginal association with diet (p = 0.079).
3.3. Association between MedDiet Adherence and Urinary Crystallization Risk
Relative to individuals with low MDS scores, those with high scores had a 0.55 PR for a high
CaUCR (95% CI = 0.29–0.90; p for trend = 0.012) in the unadjusted model and a 0.51 PR for a high
Ca CR (95 CI = 0.26–0.87; p for trend = 0.012) in the adjusted model (Table 3). Relative to those with
low MDS scores, those with high scores had a 0.74 PR for a high UrUCR (95% CI = 0.44–1.08; p for
trend = 0.042) in the unadjusted model. After adjusting for age, sex, type 2 diabetes, and BMI, this
association was no longer significant (p for trend = 0.069).
Table 3. Prevalence ratios (95% CIs) for high CaUCR and high UrUCR in groups that had low, medium,
and high adherence to the MedDiet.
Mediterranean Diet Adherence a
Low (n = 130) Medium (n = 103) High (n = 34) p for trend
CaUCR














Model 2 c ref. 0.76(0.54, 1.00)
0.77
(0.46, 1.12) 0.069
CaUCR, calcium urinary crystallization risk; UrUCR, uric acid urinary crystallization risk. a Low: MDS ≤ 3; Medium:
MDS = 4 or 5; High: MDS ≥ 6. b Model 1: Crude binary logistic regression. c Model 2: Binary logistic regression
with adjustment for age, sex, type 2 diabetes, body mass index and energy intake.
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We also analyzed the association between each of the nine components of the MDS with CaUCR
(Figure 2A) and UrUCR (Figure 2B). Consuming vegetables was associated with a significantly lower
PR of a high CaUCR (0.64, 95% CI = 0.44–0.86), and a high MUFA/SFA ratio was associated with a
significantly lower PR of a high UrUCR (0.63, 95% CI = 0.44–0.85). There were trends for associations of
moderate ethanol consumption with an increased PR of a high CaUCR, and of fish consumption with a
decreased PR of a high CaUCR and an increased PR of a high UrUCR, although these relationships
were not statistically significant.
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4. Discussion
To our knowledge, this is the first study to evaluate the relationship between the MedDiet and
lithogenic urine that separately considered CaUCR and UrUCR. The major result of our study of
participants who were overweight/obese and had the metabolic syndrome is that high adherence to
the MedDiet was associated with lower prevalence of high CaUCR and high UrUCR. For the latter
(high UrUCR), when the model was adjusted for age, sex, type 2 diabetes, and BMI, this association
was no longer significant (p for trend = 0.069) if we consider p < 0.05 as a threshold. However, a high
or low CaUCR or UrUCR index does not automatically indicate that kidney stones are present in the
individual because they are only probabilistic parameters. Many patients with kidney stones may
have normal urine composition or healthy people may have metabolic abnormalities in their urine.
A total of 48.3% of our participants had lithogenic urine and high UrUCR. Almost all of those who
had high UrUCR (96.1%) had urinary pH levels below 5.5, and the others had uric acid levels above
6.0 mM. A urinary pH below 5.5 is a relevant risk factor for formation of uric acid stones, because it can
be easily modified by diet [19]. Subjects who adhered to the MedDiet were marginally less likely to
have a high UrUCR (55.4% vs. 41.2%, p = 0.079). We also found that the main component of the MDS
associated with decreased UrUCR was a high MUFA/SFA ratio. The MUFA/SFA ratio in the MedDiet
could indicate low consumption of animal products (which are rich in saturated fats and associated
with uric acid stone formation) and/or increased consumption of monounsaturated fats, such as olive
oil. This ratio represents a healthy fatty acids intake, i.e. low intake of saturated fat from animal
products, such as red and processed meats, and high intake of mono-unsaturated fat from olive oil.
High olive oil intake is normally accompanied by high vegetable intake. This ratio, hence, represents
not only a healthy intake of fatty acids, but also an overall vegetable-rich, animal-poor diet pattern,
which might lead to lower UrUCR. Our results differ from those of the Seguimiento Universidad
de Navarra (SUN), a Spanish prospective cohort study of middle-aged university graduates which
reported increased risk of any type of renal lithiasis in those who had diets with higher MUFA/SFA
ratios, and reduced risk of any type of lithiasis in those with greater consumption of dairy products
and vegetables [21]. This may be because we examined older subjects (mean age of ~65 years), who
have an approximately two-fold increased risk of uric acid stones [22].
We found that 47.5% of our subjects had high CaUCR using previously established criteria
(Table 1). Previous studies demonstrated that nearly 100% of patients who met these criteria were
stone-formers [16–18]. We also found that subjects who better adhered to the MedDiet had a significantly
decreased CaUCR. High consumption of vegetables was the component of the MDS that was most
responsible for the decreased CaUCR. This finding is not surprising, because other studies have also
reported the protective effect of high consumption of vegetables on any kind of renal lithiasis [23,24].
Vegetables may therefore adjust the urinary pH values and reduce the urinary litogen risk [25].
Although there are not statistically significant differences in the urinary parameters between the
three categories (Table 2), we found an overall lower risk for urinary crystallization for those with
greater adherence to the MedDiet. These results are consistent with a prospective cohort study of
16,094 participants which found a marked decrease in the incidence of renal lithiasis for those with
higher adherence to the MedDiet [21]. However, this study examined the self-reported incidence of
any kind of renal lithiasis, and did not measure urinary lithogenic parameters [21].
Other diets, such as DASH-style (Dietary Approach to Stop Hypertension), have been associated
with reduced risk of kidney stones [26,27]. The DASH score and the MDS have some similarities: higher
intake of fruit, vegetables, legumes and nuts increases the score, while higher intake of meat and meat
products decreases the score. One of the differences among these diets is regarding the consumption of
dairy products. The DASH diet recommends the consumption of low-fat dairy, whereas the MedDiet
is characterized by a moderate intake of overall dairy.
Our cross-sectional study had some limitations. First, inherent to the cross-sectional design,
we cannot exclude reverse causation. Second, we did not analyze 24-h urine samples, and thus could
not measure total urinary solute excretion. Third, the urine volume was not considered because
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we used solute concentration (mg/dL) in CaUCR and UrUCR (Table 1), by which we considered
indirectly the hydration of subjects. Fourth, our study population was very specific (age of ~65 years,
overweight or obese, and with metabolic syndrome), thus the results cannot be extrapolated to the
general population or other population subgroups. However, we had a special interest in analyzing
these individuals because a previous systematic review and meta-analysis reported that individuals
with metabolic syndrome have a higher prevalence of renal lithiasis [28]. We determined long-term
dietary patterns using a validated food frequency questionnaire, but a spot urine sample is more
likely to reflect short-term dietary intake. This could potentially lead to lower sensitivity to detect
associations with individual foods and nutrients that are consumed less frequently; however, with the
use of a dietary score, we might have been able to increase sensitivity to detect such associations. Fifth,
because this was an observational cross-sectional study with a modest sample size, we cannot rule out
potential residual confounding. The strengths of our study were that we used a previously validated
food questionnaire, we had accurate measurements of urinary pH (which is not usually reported in
urine analysis), we separately analyzed urinary lithogenic risk based on CaUCR and UrUCR, and we
controlled for potential confounders in our statistical models.
In conclusion, our cohort of overweight or obese elderly subjects with metabolic syndrome had a
high prevalence of lithogenic urine. Participants with higher adherence to the MedDiet had a lower
risk for urinary crystallization by uric acid and calcium salts. Overall, our study together with previous
studies provide a rationale for establishment of randomized trials to confirm the protective role of the
MedDiet on renal lithiasis. These results suggest that following the MedDiet could reduce the urinary
lithogenic risk for uric acid and calcium salts in individuals who are elderly, overweight or obese, and
have the metabolic syndrome.
5. Conclusions
In conclusion, our cohort of overweight or obese elderly subjects with metabolic syndrome had a
high prevalence of lithogenic urine. Participants with higher adherence to the MedDiet had a lower
risk for urinary crystallization by uric acid and calcium salts. Overall, our study together with previous
studies provide a rationale for establishment of randomized trials to confirm the protective role of the
MedDiet on renal lithiasis. These results suggest that following the MedDiet could reduce the urinary
lithogenic risk for uric acid and calcium salts in individuals who are elderly, overweight or obese, and
have the metabolic syndrome.
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